Kannaway parent company Medical Marijuana, Inc. announced net revenue of $75.6 million for 2019, a 26.3 percent increase from $59.8 million in 2018.
“In 2019, Medical Marijuana, Inc. and its subsidiaries continued to execute on our strategic growth and fiscal responsibility action plan that rendered our best results yet and I could not be more excited to share them with shareholders,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We were able to not only generate increased revenues but focus on our bottom line by making strategic adjustments to expenditures.”
“In addition to our success in the U.S., our international operations have continued to flourish in Europe, Latin America and we are excited for our development in Asia,” said Medical Marijuana, Inc. COO Blake Schroeder. “We hope that these efforts will continue to build shareholder value and help bring our industry-leading products to broader audiences worldwide.”
For more information on Medical Marijuana’s 2019 financial results, click here.